期刊文献+

mTOR信号通路在胰腺癌发病中的作用 被引量:7

Role of mTOR signaling pathway in the pathogenesis of pancreatic cancer
原文传递
导出
摘要 目的检测mTOR信号通路在胰腺癌组织中的表达,探讨其在胰腺癌发病中的作用。方法选择经手术、病理证实的6例胰腺癌及相应癌旁组织,抽提RNA,应用Agilent人全基因表达谱芯片进行检测,生物信息学分析mTOR信号通路在胰腺癌组织中的表达。结果总共筛选到1276个差异基因,其中癌组织上调的有691个,下调的有585个。KEGG通路的Enrichment和基因计数两项指标得分最高的是mTOR信号通路中的hsa04150,其Enrichment为4.5622519,基因计数为9,基因计数百分率为1.15%,EASE Score P值为6.23E-04,最有生物学意义,其中ULK2、PIK3R3、PDPK1、EIF4EBP1、PGF、VEGFB、ULK3、RICTOR与PIK3R5等9个关键基因具有显著性差异(P值均〈0.05)。结论胰腺癌发病与mTOR信号通路激活密切相关。 Objectives To investigate the expression of roTOR signaling pathway in pancreatic cancer and export its signification. Methods 6 samples of pancreatic cancer and its paracaneerous tissues specimens confirmed by surgery and pathologic examination were selected. RNA was extracted and expression profiles experiment was performed by using Agilent human whole genomic oligonucleotide microarrays. The expression of roTOR signaling pathway in pancreatic cancer was analyzed by bioinformatics. Results Totally 1276 differential gene were selected, and 691 were up-regulated in cancer tissue, while 585 were down-regulated. The highest score of KEGG pathway's Enrichment and gene count was hsa04150 in roTOR signaling pathway, with its Enrichment of 4. 5622519 and gene count of 9, and the percentage of gene count was 1. 15%, the EASE Score P value was 6.23 E-04, which had the most biological significance. Among those, there was significantly difference of expression of nine key genes including ULK2, PIK3R3, PDPK1, EIF4EBP1, PGF, VEGFB, ULK3, RICTOR and PIK3R5 (P 〈 0.05). Conclusions The pathogenesis of pancreatic cancer is related to the activation of the mTOR signaling pathway.
出处 《中华胰腺病杂志》 CAS 2011年第1期28-30,共3页 Chinese Journal of Pancreatology
基金 上海市浦东新区科委科技创新资金项目(PKJ2007-Y10)
关键词 胰腺肿瘤 MTOR 信号通路 基因表达谱 Pancreatic neoplasms mTOR Signaling pathway Gene expression profiling
  • 相关文献

参考文献15

  • 1Law BK.Rapamycin:an anti-cancer inmunosuppressant? Crit Rev Oncol Hematol,2005,56:47-60.
  • 2Shaw RJ,Bardeesy N,Manning BD,et al.The LKB1 tumor suppressor negatively regulates mTOR signaling.Cancer Cell,2004,6:91-89.
  • 3Inoki K,Corradetti MN,Guan KL.Dysregulation of the TSC-mTOR pathway in human disease.Nat Genet,2005,37:19-24.
  • 4Chan S.Targeting the mammalian target of rapamycin (mTOR):a new approach to treating cancer.Br J Cancer,2004,91:1420-1424.
  • 5Mohi MG,Boulton C,Gu TL,et al.Combination of rapamycin and protein tyrosine kinase (PTK) inhibitors for the treatment of leukemias caused by oncogenic PTKs.Proc Natl Acad Sci USA,2004,101:3130-3135.
  • 6Akcakanat A,Sahin A,Shaye AN,et al.Comparison of Akt/mTOR signaling in primary breast tumors and matched distant metastases.Cancer,2008,112:2352-2358.
  • 7Yan J,Kuroyanagi H,Tomemori T,et al.Mouse ULK2,a novel member of the UNC-51-like protein kinases:unique features of functional domains.Oncogene,1999,18:5850-5859.
  • 8Chan EY,Longatti A,McKnight NC,et al.Kinase-inactivated ULK proteins inhibit autophagy via their conserved C-terminal domains using an Atg13-independent mechanism.Mol Cell Biol,2009,29:157-171.
  • 9Soroceanu L,Kharbanda S,Chen R,et al.Identification of IGF2 signaling through phosphoinositide-3-kinase regulatory subunit 3 as a growth-promoting axis in glioblastoma.Proc Natl Acad Sci USA,2007,104:3466-3471.
  • 10Zhang L,Huang J,Yang N,et al.Integrative genomic analysis of phosphatidylinositol 3'-kinase family identifies PIK3R3 as a potential therapeutic target in epithelial ovarian cancer.Clin Cancer Res,2007,13:5314-5321.

同被引文献113

引证文献7

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部